Neonatal Intensive Care Market

Neonatal Intensive Care Market Research, 2031

The global neonatal intensive care market was valued at $2.0 billion in 2021 and is projected to reach $4.4 billion by 2031, growing at a CAGR of 8.2% from 2022 to 2031. A neonatal intensive care unit (NICU), also known as an intensive care nursery (ICN), is an intensive care unit (ICU) specializing in the care of ill or premature newborn infants. Neonatal refers to the first 28 days of life. The neonatal intensive care unit (NICU) is equipped with various advanced instruments such as infant ventilators, neonatal incubators and infant warmers.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the neonatal intensive care market, owing implementation of lockdowns in many countries. The COVID-19 pandemic affected the supply chain. The entire healthcare industry has focused on life saving and COVID-19 related products during the pandemic. In addition, global economic recession led by COVID-19 further restricts growth of the market. Thus, COVID-19 have significant negative impact on the neonatal intensive care market. However, the market is anticipated to witness recovery in 2022, and show stable growth for neonatal intensive care market in the future.

The increase in the prevalence of neonatal hypothermia and rise in incidences of low birth weight of infants drives the Neonatal Intensive Care Market growth. Neonatal hypothermia is the reduction in the body temperature of the newborn (less than 36.5°C). The neonatal intensive care unit (NICU) provides care for babies who are born prematurely (before 37 weeks gestation), with a medical condition that needs treatment, or at low birth weight. In addition, an increase in the prevalence of preterm birth rate drives the growth of the market. The key factors such as the medical condition of the mother, diabetes, drug consumption, alcoholism, and multiple pregnancies contribute to the increase in the prevalence of preterm birth.

Furthermore, the increasing risk of COVID-19 infection and other respiratory diseases in newborn babies drives the growth of the market. babies under age 1 might be at higher risk of severe illness with COVID-19 than older children. According to the Centers for Disease Control and Prevention (CDC) surveillance report, from March 29–October 14, 2020, 923 newborns were born to women with COVID-19; among these newborns, 2.6% tested positive for SARS-CoV-2 after birth. Thus, the prevalence of respiratory diseases and the growing risk of COVID-19 infection propels the demand of neonatal incubators and infant ventilators.

Moreover, an increase in R&D activity for advancements in neonatal intensive care, and product approvals contribute to the growth of the market. For instance, in May 2022, Medtronic plc, a global leader in healthcare technology, received the U.S. Food and Drug Administration (FDA) granting 510(k) clearance for the Nellcor OxySoft SpO2 sensor.

The growing interest of manufacturers & developers in the development of neonatal intensive care and the latest product launch drives the growth of the Neonatal Intensive Care Industry. For instance, in November 2021, Medtronic plc, a global medical technology company, announced the U.S. commercial launch of the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine following the U.S. Food and Drug Administration's (FDA) marketing authorization. In addition, combined manufacturers' efforts for developing footprints in emerging market contributes to the growth of Neonatal Intensive Care Market size.

In addition, the increased need for the installation of NICU units and a rise in awareness among individuals regarding neonatal care is expected to boost the growth of the Neonatal Intensive Care Market size. Furthermore, growing concern for neonatal care contributes to the growth of the market.

The neonatal intensive care market is segmented into Product, Application, End User, and Region.

By product, the segment market is divided into warmers, incubators, monitoring devices, respiratory devices, phototherapy equipment, and others. The incubators are divided into hybrid incubators, normal incubators, and transport incubators. Depending on the application classified into neonatal hypothermia & low birth weight, jaundice and others. Based on the end-user market is categorized into hospitals, maternity hospitals, and neonatal & pediatric hospitals.

By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).

Depending on the product, the respiratory devices segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to advancements in neonatal intensive care and the increasing prevalence of respiratory diseases. However, the incubators segment is expected to witness considerable growth during the forecast period, due to an increase in the installation of incubators in neonatal intensive care units (NICU) and the latest product launch in the market.

Based on application, the neonatal hypothermia & low birth weight segment dominated the market in 2021, and this trend is expected to continue during the Neonatal Intensive Care Market forecast period, owing to the increasing prevalence of neonatal hypothermia and the rise in the incidence of preterm birth. However, the jaundice segment is expected to witness considerable growth during the forecast period, due to an increase in the prevalence of neonatal jaundice and premature childbirth.

By end user, the neonatal & pediatric hospital segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to a rise in the number of neonatal & pediatric hospitals and an increase in demand of advanced treatment. However, the hospital segment is expected to witness considerable growth during the forecast period, due to an increase in the number of hospitals and a rise in healthcare expenditures.

Depending on the region, Asia-Pacific garnered the major share in the Neonatal Intensive Care Market share in 2021 and is expected to dominate the global market during the forecast period, increase in product launches in the region, a rise in healthcare expenditures, and the presence of high population base. However, North America is expected to register significant growth, owing to the presence of well-established healthcare infrastructure, development in healthcare infrastructure, and the presence of key players.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neonatal intensive care market analysis from 2021 to 2031 to identify the prevailing neonatal intensive care market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
• An in-depth analysis of the neonatal intensive care market segmentation assists to determine the prevailing Neonatal Intensive Care Market opportunity.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global neonatal intensive care market trends, key players, market segments, application areas, and market growth strategies.

 Neonatal Intensive Care Market Report Highlights